Marker Therapeutics, Inc. (MRKR)

1.48 +0.03 (+2.07%) USD  |  NASDAQ  |  Feb 23, 11:29
More

Marker Therapeutics Current Tax Payable (Quarterly)

Current Tax Payable (Quarterly) Chart

View Current Tax Payable (Quarterly) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Tax Payable (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Tax Payable (Quarterly) Range, Past 5 Years

View Current Tax Payable (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Tax Payable (Quarterly) Benchmarks

View Current Tax Payable (Quarterly) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. --
ACADIA Pharmaceuticals, Inc. --
Kiniksa Pharmaceuticals International Plc --
Neurocrine Biosciences, Inc. Upgrade